Multiple sclerosis is an immune disease characterized by inflammatory demyelinating disease of the central nervous system. The disease is a lifelong disease. The main goal of treatment in remission stage is to control the progress of the disease. Disease-modifying treatment is the standard treatment in remission stage of multiple sclerosis

which can reduce the clinical attack and disability progress of patients with recurrence remission to varying degrees. In recent years

more progress has been made in the disease correction treatment of multiple sclerosis. A variety of monoclonal antibodies and oral preparations have been listed at home and abroad

providing a variety of options for the disease correction treatment of multiple sclerosis and improving the treatment effects. This paper reviews the drugs for disease-modifying treatment listed at home and abroad

so as to provide reference for clinical medication.